-
Product Name
Anti-IRAK4 Rabbit antibody
- Documents
-
Description
IRAK4 Rabbit monoclonal antibody
-
Tested applications
WB, IHC-P, ICC/IF, FC
-
Species reactivity
Human
-
Alternative names
IPD1; REN64; IRAK-4; NY-REN-64 antibody
-
Isotype
Rabbit IgG
-
Preparation
Antigen: A synthetic peptide of human IRAK4
-
Clonality
Monoclonal
-
Formulation
50nM Tris-Glycine(pH 7.4), 0.15M Nacl, 40%Glycerol, 0.01% sodium azide and 0.05% BSA.
-
Storage instructions
Store at 4°C short term. Store at -20°C long term. Avoid freeze / thaw cycle.
-
Applications
WB: 1/1000-1/5000
IHC: 1/20-1/500
ICC/IF: 1/20
FC: 1/20
-
Validations
Western blot detection of IRAK4 in Jurkat,Hela cell lysates using IRAK4 Rabbit mAb(1:1000 diluted).Predicted band size:52kDa.Observed band size:52kDa.
-
Background
Swiss-Prot Acc.Q9NWZ3.Serine/threonine-protein kinase that plays a critical role in initiating innate immune response against foreign pathogens. Involved in Toll-like receptor (TLR) and IL-1R signaling pathways (PubMed:17878374). Is rapidly recruited by MYD88 to the receptor-signaling complex upon TLR activation to form the Myddosome together with IRAK2. Phosphorylates initially IRAK1, thus stimulating the kinase activity and intensive autophosphorylation of IRAK1. Phosphorylates E3 ubiquitin ligases Pellino proteins (PELI1, PELI2 and PELI3) to promote pellino-mediated polyubiquitination of IRAK1. Then, the ubiquitin-binding domain of IKBKG/NEMO binds to polyubiquitinated IRAK1 bringing together the IRAK1-MAP3K7/TAK1-TRAF6 complex and the NEMO-IKKA-IKKB complex. In turn, MAP3K7/TAK1 activates IKKs (CHUK/IKKA and IKBKB/IKKB) leading to NF-kappa-B nuclear translocation and activation. Alternatively, phosphorylates TIRAP to promote its ubiquitination and subsequent degradation. Phosphorylates NCF1 and regulates NADPH oxidase activation after LPS stimulation suggesting a similar mechanism during microbial infections.
Related Products / Services
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"